These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


137 related items for PubMed ID: 185222

  • 1. Cell surface receptors for insulin and human growth hormone. Effect of microtubule and microfilament modifiers.
    Van Obberghen E, De Meyts P, Roth J.
    J Biol Chem; 1976 Nov 10; 251(21):6844-51. PubMed ID: 185222
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intracellular potassium depletion in IM-9 lymphocytes suppresses the slowly dissociating component of human growth hormone binding and the down-regulation of its receptors but does not affect insulin receptors.
    Ilondo MM, Courtoy PJ, Geiger D, Carpentier JL, Rousseau GG, De Meyts P.
    Proc Natl Acad Sci U S A; 1986 Sep 10; 83(17):6460-4. PubMed ID: 3018733
    [Abstract] [Full Text] [Related]

  • 6. Regulation of receptor concentration by homologous hormone. Effect of human growth hormone on its receptor in IM-9 lymphocytes.
    Lesniak MA, Roth J.
    J Biol Chem; 1976 Jun 25; 251(12):3720-9. PubMed ID: 180007
    [Abstract] [Full Text] [Related]

  • 7. Glycosylation of cell surface receptors: tunicamycin treatment decreases insulin and growth hormone binding to different levels in cultured lymphocytes.
    Keefer LM, De Meyts P.
    Biochem Biophys Res Commun; 1981 Jul 16; 101(1):22-9. PubMed ID: 6269546
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of cytochalasin congeners, microtubule-directed agents, and doxorubicin alone or in combination against human ovarian carcinoma cell lines in vitro.
    Trendowski M, Christen TD, Acquafondata C, Fondy TP.
    BMC Cancer; 2015 Sep 10; 15():632. PubMed ID: 26357852
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Site-site interactions among insulin receptors. Characterization of the negative cooperativity.
    DeMeyts P, Bainco AR, Roth J.
    J Biol Chem; 1976 Apr 10; 251(7):1877-88. PubMed ID: 5434
    [Abstract] [Full Text] [Related]

  • 15. Phenformin has opposite effects on insulin and growth hormone binding to IM-9 lymphocytes.
    Purrello F, Trischitta V, Runello F, Vigneri R.
    Metabolism; 1982 Nov 10; 31(11):1073-6. PubMed ID: 6290837
    [Abstract] [Full Text] [Related]

  • 16. Defect in cooperativity in insulin receptors from a patient with a congenital form of extreme insulin resistance.
    Taylor SI, Leventhal S.
    J Clin Invest; 1983 Jun 10; 71(6):1676-85. PubMed ID: 6345588
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Receptor-binding and down-regulatory properties of 22000-Mr human growth hormone and its natural 20000-Mr variant on IM-9 human lymphocytes.
    Smal J, Closset J, Hennen G, de Meyts P.
    Biochem J; 1985 Jan 15; 225(2):283-9. PubMed ID: 2983666
    [Abstract] [Full Text] [Related]

  • 20. Microtubules, microfilaments and the transport of acetylcholine receptors in embryonic myotubes.
    Connolly JA.
    Exp Cell Res; 1985 Aug 15; 159(2):430-40. PubMed ID: 4040866
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.